Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population
- PMID: 15753616
- DOI: 10.1159/000084302
Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population
Abstract
Recent reports have proved that genetic factors play a role in the pathogenesis of sporadic Parkinson's disease (PD). It has been suggested that polymorphisms in monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) might increase the risk of PD. A total of 210 Polish patients with sporadic PD and 152 healthy controls were studied. The MAOB and COMT polymorphisms were identified using the polymerase chain reaction-restriction fragment length polymorphism method. The MAOB allele and genotype frequencies in PD patients did not differ significantly from the controls. A statistically lower frequency of the COMTLL genotype in patients with parkinsonism was found. The combined haplotype of the MAOB G (G/G) and COMTHL genotype showed a fourfold increase (p < 0.05) in the risk of PD in female patients in this Polish population.
Copyright 2005 S. Karger AG, Basel.
Similar articles
-
The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.Acta Neurol Scand. 2004 Oct;110(4):260-6. doi: 10.1111/j.1600-0404.2004.00315.x. Acta Neurol Scand. 2004. PMID: 15355491
-
Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson's disease in an Iranian population.Folia Neuropathol. 2012;50(4):382-9. doi: 10.5114/fn.2012.32368. Folia Neuropathol. 2012. PMID: 23319194
-
Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease.Parkinsonism Relat Disord. 2007 May;13(4):224-9. doi: 10.1016/j.parkreldis.2006.10.006. Epub 2007 Jan 31. Parkinsonism Relat Disord. 2007. PMID: 17270484
-
[Role of gene polymorphism of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAOB), cytochrome P450 2D6 (CYP2D6) and N-acetyltransferase 2 (NAT2) in pathogenesis of Parkinson's disease].Neurol Neurochir Pol. 2002 Jan-Feb;36(1):113-21. Neurol Neurochir Pol. 2002. PMID: 12053603 Review. Polish.
-
Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population.Parkinsonism Relat Disord. 2014 Oct;20(10):1041-5. doi: 10.1016/j.parkreldis.2014.06.021. Epub 2014 Jul 4. Parkinsonism Relat Disord. 2014. PMID: 25034874 Review.
Cited by
-
The relationship between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease risk: a meta-analysis.Ann Saudi Med. 2014 Jan-Feb;34(1):12-7. doi: 10.5144/0256-4947.2014.12. Ann Saudi Med. 2014. PMID: 24658549 Free PMC article.
-
Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.Brain Behav. 2020 Mar;10(3):e01537. doi: 10.1002/brb3.1537. Epub 2020 Feb 5. Brain Behav. 2020. PMID: 32022467 Free PMC article.
-
Bi-directional regulation of AIMP2 and its splice variant on PARP-1-dependent neuronal cell death; Therapeutic implication for Parkinson's disease.Acta Neuropathol Commun. 2024 Jan 3;12(1):5. doi: 10.1186/s40478-023-01697-5. Acta Neuropathol Commun. 2024. PMID: 38172953 Free PMC article.
-
Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson's Disease.Curr Genomics. 2013 Dec;14(8):518-33. doi: 10.2174/1389202914666131210210241. Curr Genomics. 2013. PMID: 24532984 Free PMC article.
-
Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.BMC Neurol. 2011 Jul 25;11:89. doi: 10.1186/1471-2377-11-89. BMC Neurol. 2011. PMID: 21781348 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous